[go: up one dir, main page]

GB201801511D0 - Gene therapy - Google Patents

Gene therapy

Info

Publication number
GB201801511D0
GB201801511D0 GBGB1801511.5A GB201801511A GB201801511D0 GB 201801511 D0 GB201801511 D0 GB 201801511D0 GB 201801511 A GB201801511 A GB 201801511A GB 201801511 D0 GB201801511 D0 GB 201801511D0
Authority
GB
United Kingdom
Prior art keywords
gene therapy
therapy
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1801511.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fondazione Telethon
Ospedale San Raffaele SRL
Original Assignee
Fondazione Telethon
Ospedale San Raffaele SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fondazione Telethon, Ospedale San Raffaele SRL filed Critical Fondazione Telethon
Priority to GBGB1801511.5A priority Critical patent/GB201801511D0/en
Publication of GB201801511D0 publication Critical patent/GB201801511D0/en
Priority to IL270028A priority patent/IL270028B2/en
Priority to CN201880040639.9A priority patent/CN110785488A/en
Priority to JP2019556929A priority patent/JP7252135B2/en
Priority to HUE18724470A priority patent/HUE069690T2/en
Priority to IL320674A priority patent/IL320674A/en
Priority to DK18724470.2T priority patent/DK3612624T3/en
Priority to FIEP18724470.2T priority patent/FI3612624T3/en
Priority to KR1020197034111A priority patent/KR102733541B1/en
Priority to EP24202037.8A priority patent/EP4491233A3/en
Priority to PT187244702T priority patent/PT3612624T/en
Priority to PL18724470.2T priority patent/PL3612624T3/en
Priority to EA201992514A priority patent/EA201992514A1/en
Priority to BR112019021953-6A priority patent/BR112019021953A2/en
Priority to ES18724470T priority patent/ES2995785T3/en
Priority to HRP20241603TT priority patent/HRP20241603T1/en
Priority to SG11201909814W priority patent/SG11201909814WA/en
Priority to SM20240506T priority patent/SMT202400506T1/en
Priority to SI201831181T priority patent/SI3612624T1/en
Priority to EP18724470.2A priority patent/EP3612624B1/en
Priority to CA3060145A priority patent/CA3060145A1/en
Priority to US16/604,484 priority patent/US20200078408A1/en
Priority to AU2018253959A priority patent/AU2018253959B2/en
Priority to RS20241344A priority patent/RS66264B1/en
Priority to PCT/EP2018/060238 priority patent/WO2018193119A1/en
Priority to LTEPPCT/EP2018/060238T priority patent/LT3612624T/en
Priority to MX2024012024A priority patent/MX2024012024A/en
Priority to MX2024012023A priority patent/MX2024012023A/en
Priority to JP2023046113A priority patent/JP2023078376A/en
Ceased legal-status Critical Current

Links

GBGB1801511.5A 2017-04-21 2018-01-30 Gene therapy Ceased GB201801511D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GBGB1801511.5A GB201801511D0 (en) 2018-01-30 2018-01-30 Gene therapy
LTEPPCT/EP2018/060238T LT3612624T (en) 2017-04-21 2018-04-20 Gene therapy
ES18724470T ES2995785T3 (en) 2017-04-21 2018-04-20 Gene therapy
HRP20241603TT HRP20241603T1 (en) 2017-04-21 2018-04-20 GENE THERAPY
JP2019556929A JP7252135B2 (en) 2017-04-21 2018-04-20 gene therapy
HUE18724470A HUE069690T2 (en) 2017-04-21 2018-04-20 Gene therapy
IL320674A IL320674A (en) 2017-04-21 2018-04-20 Gene therapy
DK18724470.2T DK3612624T3 (en) 2017-04-21 2018-04-20 GEN THERAPY
FIEP18724470.2T FI3612624T3 (en) 2017-04-21 2018-04-20 Gene therapy
KR1020197034111A KR102733541B1 (en) 2017-04-21 2018-04-20 Gene therapy
EP24202037.8A EP4491233A3 (en) 2017-04-21 2018-04-20 Gene therapy
PT187244702T PT3612624T (en) 2017-04-21 2018-04-20 Gene therapy
PL18724470.2T PL3612624T3 (en) 2017-04-21 2018-04-20 GENE THERAPY
EA201992514A EA201992514A1 (en) 2018-01-30 2018-04-20 GENE THERAPY
BR112019021953-6A BR112019021953A2 (en) 2017-04-21 2018-04-20 hematopoietic stem cell, hematopoietic progenitor cell, myeloid/monocyte-compromised progenitor cell, macrophage or monocyte, tumor-associated antigen-specific t-cell, immune checkpoint inhibitor, 1-methyl-tryptophan, combination of a point inhibitor checkpoint and a tumor-associated antigen-specific t-cell, method for treating or preventing a cancer, and, hematopoietic stem cell population, hematopoietic progenitor cells, myeloid/monocyte-compromised progenitor cells, macrophages, or monocytes.
IL270028A IL270028B2 (en) 2017-04-21 2018-04-20 Gene therapy
SM20240506T SMT202400506T1 (en) 2017-04-21 2018-04-20 GENE THERAPY
CA3060145A CA3060145A1 (en) 2017-04-21 2018-04-20 Cytokine gene therapy for treating or preventing cancer
SG11201909814W SG11201909814WA (en) 2017-04-21 2018-04-20 Gene therapy
SI201831181T SI3612624T1 (en) 2017-04-21 2018-04-20 Gene therapy
EP18724470.2A EP3612624B1 (en) 2017-04-21 2018-04-20 Gene therapy
CN201880040639.9A CN110785488A (en) 2017-04-21 2018-04-20 gene therapy
US16/604,484 US20200078408A1 (en) 2017-04-21 2018-04-20 Gene therapy
AU2018253959A AU2018253959B2 (en) 2017-04-21 2018-04-20 Gene therapy
RS20241344A RS66264B1 (en) 2017-04-21 2018-04-20 GENE THERAPY
PCT/EP2018/060238 WO2018193119A1 (en) 2017-04-21 2018-04-20 Gene therapy
MX2024012023A MX2024012023A (en) 2017-04-21 2019-10-21 COMBINATIONS FOR USE IN THE TREATMENT OR PREVENTION OF CANCER
MX2024012024A MX2024012024A (en) 2017-04-21 2019-10-21 Gene therapy
JP2023046113A JP2023078376A (en) 2017-04-21 2023-03-23 gene therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1801511.5A GB201801511D0 (en) 2018-01-30 2018-01-30 Gene therapy

Publications (1)

Publication Number Publication Date
GB201801511D0 true GB201801511D0 (en) 2018-03-14

Family

ID=61558314

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1801511.5A Ceased GB201801511D0 (en) 2017-04-21 2018-01-30 Gene therapy

Country Status (2)

Country Link
EA (1) EA201992514A1 (en)
GB (1) GB201801511D0 (en)

Also Published As

Publication number Publication date
EA201992514A1 (en) 2020-02-25

Similar Documents

Publication Publication Date Title
PT3612624T (en) Gene therapy
GB201804255D0 (en) Macrophage-based therapy
PL3262066T3 (en) Gene therapy
HUE056570T2 (en) Gene therapy
IL280165A (en) Glucocerebrosidase gene therapy
IL279685A (en) Gene therapy
GB201905301D0 (en) Gene therapy
GB201819853D0 (en) Therapy
GB201900702D0 (en) Therapy
ZA202100244B (en) Combinatorial gene therapy
GB201707212D0 (en) Gene therapy for ciliopathies
GB201802326D0 (en) Gene therapy
IL275613A (en) Gene therapy for eosinohilic disorders
GB201817470D0 (en) Gene therapy
GB201701968D0 (en) Gene therapy
GB201817385D0 (en) Therapy
GB201818579D0 (en) New therapy
GB201814036D0 (en) New therapy
GB201820982D0 (en) Gene Therapy
GB201811541D0 (en) Gene therapy
GB201801511D0 (en) Gene therapy
GB201919036D0 (en) Therapy
GB201916983D0 (en) Therapy
GB201914848D0 (en) Therapy
GB201913785D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)